MDT Medtronic
Q1 2026 10-Q
Filed: Feb 24, 2026Period ending Jan 23, 2026
Health Care
Electromedical & Electrotherapeutic ApparatusSEC EDGAR Medtronic (MDT) 10-Q quarterly report for Q1 2026, filed with SEC EDGAR on Feb 24, 2026 for the fiscal period ending Jan 23, 2026. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ1 2026 10-Q
Management Discussion & Analysis
- • Q3 FY2026 total net sales $9.0B, up ~9% YoY from $8.3B; nine-month sales $26.6B vs $24.6B prior year
- • GAAP effective tax rate 18.1% vs 15.4% YoY; GAAP net income $1.14B vs $1.29B YoY; non-GAAP EPS $1.36 vs $1.39 YoY
Risk Factors
- • Section 'risk_factors' was empty or not found.
Quarterly Financial SummaryXBRL
Revenue
$8.6B
Net Income
$1.0B
Operating Margin
16.8%
Net Margin
12.1%
Source: XBRL data from Medtronic Q1 2026 10-Q filing on SEC EDGAR. All figures in USD.
Other Medtronic Quarterly Reports
Get deeper insights on Medtronic
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.